Results 81 to 90 of about 2,019 (102)

PP147 What Does Real World Evidence (RWE) Offer Health Technology Assessment (HTA) Procedures In Australia?

International Journal of Technology Assessment in Health Care, 2023
IntroductionMedical device health technology assessment (HTA) in Australia is largely coordinated by the Medical Services Advisory Committee (MSAC). Its remit to improve the public’s health by deciding where to allocate public healthcare funding, can be enhanced by considering real world evidence (RWE).
Gabrielle Challis, Michelle Hill, Liesl Strachan, Kate King, Shajedur Rahman Shawon, Oluwadamisola Sotade, Louisa Jorm   +6 more
openaire   +1 more source

PP147. Prevalence of hypertensive syndromes according to pregnancy age

Pregnancy Hypertension: An International Journal of Women's Cardiovascular Health, 2012
The decision of a woman to get pregnant at later age of her reproductive cycle has be a phenomenon around the world. Epidemiology data show frequent increase of clinical complications in direct proportion in advanced age motherhood, hypertensive disturbances being more prevalent.Analyse the prevalence of hypertensive syndromes in pre-determined age ...
G M, Dias, A M, Godoi, M R L N, Paltronieri, R P, Soares, S F, Toledo, M R F, Curty, V, Tarricone, M L C, David, F L P, Sousa, J M, Garcia, R G R, Guidoni, J R, Del Sant, D R A, Porto   +12 more
openaire   +2 more sources

PP147 Olaratumab With Doxorubicin For Advanced Soft Tissue Sarcoma

International Journal of Technology Assessment in Health Care, 2018
Introduction:The National Institute for Health and Care Excellence (NICE) invited the manufacturer of olaratumab (Lartruvo®), Eli Lilly & Company Limited, to submit evidence for the clinical and cost effectiveness of this drug, in combination with doxorubicin, for advanced soft tissue sarcoma (STS) not amenable to surgery or radiotherapy, as part ...
Irina Tikhonova, Tracey Jones-Hughes, James Dunham, Fiona Warren, Sophie Robinson, Martin Hoyle   +5 more
openaire   +1 more source

PP147 Physician And Patient Reported Anxiety And Depression In Hemophilia

International Journal of Technology Assessment in Health Care, 2017
INTRODUCTION:Anxiety and depression are major drivers of health-related quality of life, adherence to therapy, and motivation to self-manage chronic conditions. A number of studies have shown rates of anxiety and depression to be higher among individuals with hemophilia compared to that of the general population (1).
Ian Jacob, Charlotte Camp, Jamie O'Hara, Mark Skinner, Shaun Walsh   +4 more
openaire   +1 more source

PP147-MON: Malnutrition, Sarcopenia and Quality of Life in Cancer Patients

Clinical Nutrition, 2014
adequate. High risk for DRM (NRS score 3) was present in 164 (27.5%) patients, 120 (20.1%) were at low risk (score 1 2), and 313 (52.4%) had no risk at all. Patients at high risk were significantly older (60.9±18.9 y; p < 0.001) than patients with low and no risk (58.8±18.2 y and 54.4±14.6 y), had a longer length of stay (10.8±12.0 d vs.
I. Alparslan, C. Ates, S. Demirer
openaire   +1 more source

PP147

Oral Oncology, 2013
Manuel Acosta-Feria, Juan Jose Haro-Luna, Benito Ramos-Medina, Antonio Gomez-Poveda, Raquel Villar-Puchades   +4 more
openaire   +1 more source

PP147-SUN PRE-CACHEXIA AND CACHEXIA IN SURGICAL CANCER PATIENTS

Clinical Nutrition Supplements, 2012
S. Lucia, G. Vuolo, R. Verzaro, C. Ramaccini, A. Mollino, F. Rossi Fanelli, A. Laviano, M. Muscaritoli   +7 more
openaire   +1 more source